• Palbociclib
  • Palbociclib

Palbociclib

Login for price

Sorry! Our Palbociclib is currently sold out.

Want to be notified when it becomes available again? Simply register your interest and we'll send you a message when it does.

Login for Price
Free Delivery
Lorem Ipsum dummy
Big Savings
Lorem Ipsum dummy
Customer Care
Lorem Ipsum dummy
Gift Voucher
Lorem Ipsum dummy

Active Ingredient: Palbociclib

Therapeutic Class: CDK4/6 Inhibitor

Indications: HR+/HER2- advanced or metastatic breast cancer in combination with hormone therapy

Dosage Form: Capsules or tablets (75 mg, 100 mg, 125 mg)

Manufacturer: Pfizer (USA)

Administration Advice: Taken orally once daily for 21 days followed by 7-day break; adjust dose based on toxicity

Certification / Approval Status: Approved in over 90 countries, including US, EU, Canada, Japan

Special Notes: Monitor blood counts regularly (risk of neutropenia)